Commentary: Benzodiazepine (BZD) and Related BZD-Receptor Agonists: Basic Science Reasons to Limit to Four Weeks or Less
Open Access
- 1 January 2019
- journal article
- Published by Scientific Research Publishing, Inc. in Pharmacology & Pharmacy
- Vol. 10 (08), 357-364
- https://doi.org/10.4236/pp.2019.108029
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit:
- The translocator protein (TSPO): A novel target for cancer chemotherapyThe International Journal of Biochemistry & Cell Biology, 2013